Company Filing History:
Years Active: 2001-2003
Title: Steve A. Schroeder: Innovator in Pharmaceutical Chemistry
Introduction
Steve A. Schroeder is a notable inventor based in Belvidere, IL (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of novel compounds. With a total of 2 patents, his work has implications for drug development and formulation.
Latest Patents
Schroeder's latest patents include the synthesis of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester using L-α-aspartyl-L-phenylalanine 1-methyl ester precursors. This innovative method involves the hydrogenation of a mixture of 3,3-dimethylbutyraldehyde and a precursor of L-α-aspartyl-L-phenylalanine 1-methyl ester. The production method is noted for its efficiency and low cost compared to conventional synthesis methods. Additionally, he has developed a novel amorphous N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester compound, which exhibits improved solubility and dissolution properties compared to the known monohydrate.
Career Highlights
Steve A. Schroeder is currently associated with The Nutrasweet Company, where he continues to innovate in the field of pharmaceutical chemistry. His work has been instrumental in advancing the synthesis of complex compounds that are crucial for various applications in the industry.
Collaborations
Schroeder has collaborated with notable colleagues such as Run Wang and Indra Prakash, contributing to a dynamic research environment that fosters innovation and development.
Conclusion
Steve A. Schroeder's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as a significant inventor in the field. His innovative approaches to compound synthesis are paving the way for advancements in drug formulation and delivery.